Join
Live feed
·
INSIDERFilingvia Quantisnow
PhaseBio Pharmaceuticals Inc. logo

SEC Form 4: Burkhardt Glen was granted 11,248 shares and sold $8,886 worth of shares (11,248 units at $0.79) as part of a pre-agreed trading plan

ByQuantisnow·Wall Street's wire, on your screen.
PHAS· PhaseBio Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAS (PhaseBio Pharmaceuticals Inc.) and more on Quantisnow.